A. V. D. van der Ark

发表

Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity.

J. Pennings, W. Jiskoot, G. Kersten, 2015, Journal of proteome research.

The Role of Virulence Proteins in Protection Conferred by Bordetella pertussis Outer Membrane Vesicle Vaccines

E. van Riet, R. Raeven, L. van der Maas, 2020, Vaccines.

A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.

H. Kallel, A. V. D. van der Ark, S. Rourou, 2007, Vaccine.

Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.

P. A. van der Ley, M. Rumbo, A. V. D. van der Ark, 2011, Vaccine.

Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.

M. Daha, L. van Es, J. Radl, 1989, Kidney international.

The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.

M. Daha, R. Valentijn, L. van Es, 1988, Clinical and experimental immunology.

Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.

M. Stork, P. A. van der Ley, A. V. D. van der Ark, 2016, Vaccine.

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine.

P. Roholl, P. A. van der Ley, J. Poolman, 1996, Vaccine.

CD59 expressed by human endothelial cells functions as a protective molecule against complement‐mediated lysis

M. Daha, L. van Es, A. V. D. van der Ark, 1992, European journal of immunology.

Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma.

Robert B Sim, M. Daha, P. Hiemstra, 1989, Journal of immunology.

An improved whole cell pertussis vaccine with reduced content of endotoxin

D. S. Horton, B. Kuipers, A. V. D. van der Ark, 2013, Human vaccines & immunotherapeutics.

Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.

P. A. van der Ley, M. Rumbo, A. V. D. van der Ark, 2014, Vaccine.

Pertussis Serological Potency Test as an Alternative to the Intracerebral Mouse Protection Test: Development, Evaluation and Validation.

C. Hendriksen, A. V. D. van der Ark, Ineke von Straaten-Van De Kappelle, 1998, ALTEX.

Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells.

M. Daha, A. Stegmann, L. van Es, 1991, The Journal of clinical investigation.

Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1.

M. Daha, W. Buurman, L. van Es, 1990, Journal of immunology.

Development of an animal‐component free medium for vero cells culture

H. Kallel, A. V. D. van der Ark, S. Rourou, 2009, Biotechnology progress.

Proteome Analysis Is a Valuable Tool to Monitor Antigen Expression during Upstream Processing of Whole-Cell Pertussis Vaccines.

J. Pennings, J. van den Ijssel, L. A. van der Pol, 2017, Journal of proteome research.

Naturally circulating pertactin-deficient Bordetella pertussis strains induce distinct gene expression and inflammatory signatures in human dendritic cells

R. Mariman, R. Jacobi, J. V. van Putten, 2021, Emerging microbes & infections.

Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.

M. Daha, P. Hiemstra, L. van Es, 1988, Clinical and experimental immunology.

Resurgence of pertussis calls for re-evaluation of pertussis animal models

C. Boog, C. V. van Els, A. V. D. van der Ark, 2012, Expert review of vaccines.

Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains

A. V. D. van der Ark, A. King, M. van Gent, 2013, PloS one.

Reducing variation in a rabbit vaccine safety study with particular emphasis on housing conditions and handling

R. van den Bos, G. van Amerongen, C. Hendriksen, 2009, Laboratory animals.

The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.

K. Enssle, R. Olander, A. V. D. van der Ark, 1999, Biologicals : journal of the International Association of Biological Standardization.

Immunoglobulin synthesis by peripheral blood lymphocytes in patients with ankylosing spondylitis.

A. Cats, L. van Es, M. Daha, 1988, The Journal of rheumatology.

Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.

A. V. D. van der Ark, A. Akkermans, C. Hendriksen, 1994, Biologicals : journal of the International Association of Biological Standardization.

In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines

R. Raeven, A. V. D. van der Ark, B. Metz, 2023, Scientific reports.

Erratum: Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination

J. Pennings, W. van Eden, W. Jiskoot, 2018, Mucosal Immunology.

Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity.

J. Pennings, W. Jiskoot, G. Kersten, 2015, Journal of proteome research.

Improving the cellular pertussis vaccine: increased potency and consistency.

M. Thalen, J. van den Ijssel, C. Beuvery, 2008, Vaccine.